Advertisement
Advertisement
IART
Integra LifeSciences Holdings
11.27
USDSponsored
+0.38
+3.54%
Feb 06, 15:59 UTC -5
Closed
After-Market
11.28
+0.01
+0.13%
IART Earnings Reports
Positive Surprise Ratio
IART beat 23 of 40 last estimates.
57%
Next Report
Date of Next Report
Feb 25, 2026
Estimate for Q4 25 (Revenue/ EPS)
$438.21M
/$0.81
Implied change from Q3 25 (Revenue/ EPS)
+8.99%
/+50.00%
Implied change from Q4 24 (Revenue/ EPS)
-1.00%
/-16.49%
Integra LifeSciences Holdings earnings per share and revenue
On Oct 30, 2025, IART reported earnings of 0.54 USD per share (EPS) for Q3 25, beating the estimate of 0.44 USD, resulting in a 21.70% surprise. Revenue reached 402.06 million, compared to an expected 422.54 million, with a -4.85% difference. The market reacted with a -23.46% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 12 analysts forecast an EPS of 0.81 USD, with revenue projected to reach 438.21 million USD, implying an increase of 50.00% EPS, and increase of 8.99% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Mesa Laboratories Inc
Report Date
Feb 03, 2026 For Q3 26
Estimate
$0.28
Actual
$3.07
Surprise
+987.88%
Accuray Incorporated
Report Date
Feb 04, 2026 For Q2 26
Estimate
-$0.11
Actual
-$0.11
Surprise
+1.96%
Thermo Fisher Scientific, Inc.
Report Date
Jan 29, 2026 For Q4 25
Estimate
$6.51
Actual
$6.57
Surprise
+0.91%
Idexx Laboratories Inc
Report Date
Feb 02, 2026 For Q4 25
Estimate
$2.98
Actual
$3.08
Surprise
+3.12%
IQVIA Holdings Inc.
Report Date
Feb 05, 2026 For Q4 25
Estimate
$3.43
Actual
$3.42
Surprise
-0.34%
Mettler-Toledo International
Report Date
Feb 05, 2026 For Q4 25
Estimate
$12.92
Actual
$13.36
Surprise
+3.34%
STERIS plc
Report Date
Feb 04, 2026 For Q3 26
Estimate
$2.55
Actual
$2.52
Surprise
-0.99%
Hologic Inc
Report Date
Jan 29, 2026 For Q1 26
Estimate
$1.11
Actual
$1.04
Surprise
-6.45%
FAQ
What were Integra LifeSciences Holdings's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Integra LifeSciences Holdings reported EPS of $0.54, beating estimates by 21.7%, and revenue of $402.06M, -4.85% below expectations.
How did the market react to Integra LifeSciences Holdings's Q3 2025 earnings?
The stock price moved down -23.46%, changed from $15.43 before the earnings release to $11.81 the day after.
When is Integra LifeSciences Holdings expected to report next?
The next earning report is scheduled for Feb 25, 2026.
What are the forecasts for Integra LifeSciences Holdings's next earnings report?
Based on 12
analysts, Integra LifeSciences Holdings is expected to report EPS of $0.81 and revenue of $438.21M for Q4 2025.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement